Are antipsychotic prescribing patterns different in older and younger adults?: A survey of 1357 psychiatric inpatients in Toronto

Canadian Journal of Psychiatry

Volumn 55, Issue 4, 2010, Pages 248-254

  Sproule, Beth A ^a,b   Lake, Jennifer ^c   Mamo, David C ^a,b   Uchida, Hiroyuki ^a,d   Mulsant, Benoit H ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c South East Toronto Family Health Team ^*  (Canada)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Antipsychotics; Elderly; Prescribing patterns

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG DOSE COMPARISON; DYSTHYMIA; GROUPS BY AGE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MEDICAL RECORD; MEDICAL SOCIETY; MENTAL HEALTH; MENTAL PATIENT; MONOTHERAPY; PRESCRIPTION; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; WORLD HEALTH ORGANIZATION;

EID: 77951661765     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500408     Document Type: Article

References (18)

1. Uchida H, Mamo DC, Mulsant BH, et al. Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms. J Clin Psychiatry. 2009;70(3):397-405.
2. Uchida H, Kapur S, Mulsant BH, et al. Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms. Am J Geriatr Psychiatry. 2009;17(3):255-263.
3. Alexopoulos GS, Streim J, Carpenter D, et al. Using antipsychotic agents in older patients. J Clin Psychiatry. 2004;65(Suppl 2):5-99.
4. Addington D, Bouchard RH, Goldberg J, et al. Clinical practice guidelines: treatment of schizophrenia. Can J Psychiatry. 2005;50:7S-57S.
5. Ito H, Koyama A, Higuchi T. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. Br J Psychiatry. 2005;187:243-247. (Pubitemid 41306105)
6. Procyshyn RM, Kennedy NB, Tse G, et al. Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution. Can J Psychiatry. 2001;46:334-339. (Pubitemid 32531565)
7. Sohler NL, Walkup J, McAlpine D, et al. Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia. Psychiatr Serv. 2003;54:1258-1263. (Pubitemid 37055988)
8. Leslie DL, Rosenheck RA. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors. Med Care. 2001;39:923-933.
9. Rapoport M, Mamdani M, Shulman KI, et al. Antipsychotic use in the elderly: shifting trends and increasing costs. Int J Geriatr Psychiatry. 2005;20:749-753. (Pubitemid 41158720)
10. Percudani M, Barbui C, Fortino I, et al. Antipsychotic drug prescribing in the elderly is cause for concern. Int Clin Psychopharmacol. 2004;19:347-350. (Pubitemid 39506990)
11. Sim K, Su A, Fujii S, et al. Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. Br J Clin Pharmacol. 2004;58:178-183. (Pubitemid 39043998)
12. Diaz FJ, De Leon J. Excessive antipsychotic dosing in 2 US State hospitals. J Clin Psychiatry. 2002;63:998-1003. (Pubitemid 35388058)
13. Uchida H, Suzuki T, Mamo DC, et al. Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1418 patients in Japan. Am J Geriatr Psychiatry. 2008;16:584-593.
14. Hirdes JP, Smith TF, Rabinowitz T, et al. The Resident Assessment Instrument-Mental Health (RAI-MH): inter-rater reliability and convergent validity. J Behav Health Serv Res. 2002;29(4):419-432. (Pubitemid 38155317)
15. Mamo DC, Sweet RA, Chengappa KN, et al. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. Int J Geriatr Psychiatry. 2002;17:1012-1017.
16. Ghaemi SN, Hsu DJ, Thase ME, et al. Pharmacological treatment patterns at study entry for the first 500 STEP-BD participants. Psychiatr Serv. 2006;57:660-665.
17. Beyer JL, Burchitt B, Gersing K, et al. Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder. Psychopharmacol Bull. 2008;41:102-114.
18. Gao K, Kemp DE, Ganocy SJ, et al. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J Clin Psychopharmacol. 2008;28:203-209. (Pubitemid 351417126)